The trademark Bioloka was filed by Alexis Hadelin R Mertens, a national of "PS" (the "Applicant"). The application was published for oppositions on August 7, 2013, and received one opposition filed on November 6, 2013 by Melisana AG on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute, (c) Earlier non registered TM & right to prohibit use of later TM under national law. the opponent was represented by MAUCHER JENKINS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 6, 2013
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
A total of undefined cancellation proceedings were initiated against the trademark registration in 2014.The first Cancellation was filed by Melisana AG (represented by LOSCHELDER) on February 10, 2023 and Final decision – EUTM partially cancelled.
The renewal of the trademark was recorded by the office on April 13, 2023.
Application for revocation or for a declaration of invalidity of the trademark registration was recorded on August 31, 2020. Deletion of the representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 14, 2021. Change of name and professional address of the trademark registration was recorded on April 10, 2022. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on February 14, 2023. Deletion of the representative of the trademark registration was recorded on April 25, 2023. A transfer of the trademark registration was recorded on October 16, 2023.
The Opposition with reference B 002271503 was rejected according to Article 8(1)(b) CTMR with decision issued on September 1, 2014 by the EUIPO. The Cancellation with reference B 000046167 was EUTM partially cancelled according to Article 58(1)(a) EUTMR with decision issued on November 10, 2022 by the EUIPO.